14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 TRVI stock ended at $2.94. This is 2.65% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.14% from a day low at $2.92 to a day high of $3.07.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Trevi Therapeutics Inc. prices

Date Open High Low Close Volume
May 06, 2024 $3.05 $3.07 $2.92 $2.94 46 638
May 03, 2024 $3.02 $3.12 $2.98 $3.02 25 273
May 02, 2024 $2.89 $3.05 $2.87 $3.01 84 086
May 01, 2024 $2.93 $3.00 $2.74 $2.86 171 165
Apr 30, 2024 $2.88 $3.09 $2.88 $2.93 252 219
Apr 29, 2024 $2.79 $2.97 $2.78 $2.94 106 829
Apr 26, 2024 $2.50 $2.80 $2.50 $2.78 53 740
Apr 25, 2024 $2.63 $2.68 $2.45 $2.54 169 812
Apr 24, 2024 $2.85 $2.87 $2.57 $2.65 122 712
Apr 23, 2024 $2.95 $3.15 $2.82 $2.85 172 290
Apr 22, 2024 $2.86 $3.06 $2.77 $2.94 192 904
Apr 19, 2024 $2.66 $2.92 $2.59 $2.84 141 867
Apr 18, 2024 $2.56 $2.87 $2.41 $2.69 178 842
Apr 17, 2024 $2.67 $2.67 $2.35 $2.58 249 858
Apr 16, 2024 $2.76 $2.83 $2.64 $2.67 116 921
Apr 15, 2024 $2.90 $2.94 $2.76 $2.81 55 807
Apr 12, 2024 $2.93 $3.05 $2.86 $2.92 92 632
Apr 11, 2024 $2.76 $3.10 $2.75 $2.98 151 173
Apr 10, 2024 $2.75 $2.90 $2.60 $2.73 240 424
Apr 09, 2024 $3.15 $3.19 $2.83 $2.88 552 593
Apr 08, 2024 $3.06 $3.15 $3.03 $3.14 75 779
Apr 05, 2024 $3.08 $3.19 $3.03 $3.07 332 177
Apr 04, 2024 $3.16 $3.25 $3.07 $3.11 258 684
Apr 03, 2024 $3.19 $3.24 $3.03 $3.16 215 922
Apr 02, 2024 $3.30 $3.30 $3.15 $3.23 104 359
Click to get the best stock tips daily for free!

About Trevi Therapeutics Inc.

Trevi Therapeutics. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo P... TRVI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT